Conditions: Healthy
Allocation: NON_RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 25
Healthy volunteers: yes

Brief summary:
The primary objective of this trial is to investigate effect of faldaprevir on steady state pharmacokinetics of raltegravir.

The assessment of safety and tolerability will be an additional objective of this trial.

Detailed description:

Arms:
arm 1: coated tablets, oral administration with 240 ml water arm 2: coated tablets and soft gelatine capsule, oral administration with 240 ml water

Interventions: intervention 1: Raltegravir intervention 2: Raltegravir intervention 3: Faldaprevir
Intervention descriptions: intervention 1: low dose oral administration intervention 2: low dose oral administration intervention 3: medium dose oral administration

Protocol document: